Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Clinical and Molecular Hepatology
>
2020
>
26
>
2
Volume:
26
Issue:
2
1. Limited expression of toll-like receptor 9 on T cells andits functional consequences in patients with nonalcoholicfatty liver disease
Page:240—241
2. Intricate interpretation of etiology-specific outcomecomparison in patients with hepatocellular carcinoma
Page:238—239
3. Does limited expression of toll-like receptor 9 actuallycontribute to T cell activation and liver damage in nonalcoholicsteatohepatitis?
Page:236—237
4. A challenge in distinguishing between acute hepatitis Band acute exacerbation of chronic hepatitis B
Page:233—235
5. Fibrolamellar hepatocellular carcinoma-related hyperammonemicencephalopathy: Up to now and next steps
Page:231—232
6. Multimodal sequential treatment for occluded TIPS:Case report and review of literature
Page:227—230
7. Limited expression of TLR9 on T cells and its functionalconsequences in patients with nonalcoholic fatty liverdisease
Page:216—226
8. Trends in the prevalence of chronic liver disease in theKorean adult population, 1998–2017
Page:209—215
9. Comparisons between non-alcoholic steatohepatitisand alcohol-related hepatocellular carcinoma
Page:196—208
10. The dilemma of differentiating between acute hepatitisB and chronic hepatitis B with acute exacerbation: Isquantitative serology the answer?
Page:187—195
11. Toll-like receptor 9, a possible blocker of non-alcoholicsteatohepatitis?
Page:185—186
12. Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
Page:183—184
13. Should physicians go out of the way to differentiatebetween acute hepatitis B and acute exacerbation ofchronic hepatitis B?
Page:180—182
14. Regulated differentiation of stem cells into an artificial3D liver as a transplantable source
Page:163—179
15. Switching to systemic therapy after locoregionaltreatment failure: Definition and best timing
Page:155—162
16. Drug induced liver injury: East versus West– a systematic review and meta-analysis
Page:142—154
17. Application of transient elastography in nonalcoholicfatty liver disease
Page:128—141
18. KASL clinical practice guidelines for liver cirrhosis:Varices, hepatic encephalopathy, and relatedcomplications
Page:83—127